Answers are grounded in this paper and cite their sources.
Chitosan stimulates the fibroblastic, endothelial, and intestinal epithelial cells to release chemotactic inflammatory cytokines, especially interleukin 8 (IL-8). Tannic acid (TA) has a variety of biological activities, such as anti-inflammatory, anti-viral effects. However, the pre-treatment of TA on chitosan polymer-induced IL-8 production from epithelial cells has not been well studied. This study focused on the effect of TA on chitosan polymer-induced IL-8 production in the oral mucosal epithelium as estimated by HSC-2 cells established from a human oral squamous cell carcinoma. The intracellular IL-8 production was measured by flow cytometry. The chitosan polymer-induced production of IL-8 decreased after pre-treatment with TA. IL-8 mRNA was measured by real-time PCR, and its mRNA expression level was reduced after TA pre-treatment. Antibody-based assays were used to investigate the effect of chitosan and TA on the activation of mitogen-activated protein kinases (MAPKs). These investigations showed the pre-treatment effects of TA on IL-8 production to be mainly mediated through the inhibition of the p38 MAPK pathways. The present study demonstrated that TA pre-treatment reduced the intracellular IL-8 production in HSC-2 cells via the MAPK signaling pathways. These findings indicate that the combined application of TA and chitosan may be clinically beneficial for the inflammatory lesions of the oral mucosa.
No takes yet. Share an insight, caveat, or question.
Ishizaki et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: